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Abstract
Background: Genetic variation at NAT2 has been long recognized as the cause of differential ability to metabolize a wide
variety of drugs of therapeutic use. Here, we explore the pattern of genetic variation in 12 human populations that
significantly extend the geographic range and resolution of previous surveys, to test the hypothesis that different dietary
regimens and lifestyles may explain inter-population differences in NAT2 variation.
Methodology/Principal Findings: The entire coding region was resequenced in 98 subjects and six polymorphic positions
were genotyped in 150 additional subjects. A single previously undescribed variant was found (34T.C; 12Y.H). Several
aspects of the data do not fit the expectations of a neutral model, as assessed by coalescent simulations. Tajima’s D is
positive in all populations, indicating an excess of intermediate alleles. The level of between-population differentiation is
low, and is mainly accounted for by the proportion of fast vs. slow acetylators. However, haplotype frequencies significantly
differ across groups of populations with different subsistence.
Conclusions/Significance: Data on the structure of haplotypes and their frequencies are compatible with a model in which
slow-causing variants were present in widely dispersed populations before major shifts to pastoralism and/or agriculture. In
this model, slow-causing mutations gained a selective advantage in populations shifting from hunting-gathering to
pastoralism/agriculture. We suggest the diminished dietary availability of folates resulting from the nutritional shift, as the
possible cause of the fitness increase associated to haplotypes carrying mutations that reduce enzymatic activity.
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Introduction
Arylamine N-acetyltransferases (NATs) are drug-metabolizing
enzymes that catalyze the conjugation of an acetyl group from
acetyl CoA onto an amine, hydrazine or hydroxylamine moiety of
an aromatic compound [1]. In humans, duplicated genes encode
for two enzymes (NAT1 and NAT2) with distinct, but partially
overlapping substrate specificities and with different tissue
distribution: NAT1 is virtually ubiquitous, whereas NAT2 is
expressed at high levels only in the intestine and liver [2]. NAT1
specific substrates include para-aminobenzoate (PABA), 4-amino-
salicylic acid and para-aminobenzoylglutamate (pABGlu, a folate
catabolite) [3–5]. NAT2 is active on a wide range of substrates, but
particularly arylhydrazine compounds, thus providing a major
route to detoxification.
Genetic variation at NAT2 has been long recognized as the
cause of differential ability to metabolize a wide variety of drugs of
therapeutic use in diseases with high prevalence such as
tuberculosis, arrhythmia and hypertension [6]. In fact, three
major phenotypes are observed, i.e. the fast, intermediate and slow
acetylators, which are inherited as a codominant trait. It is also
recognized that the different activity of the allelic isoenzymes
results in altered activation/deactivation of many compounds that
are commonly found in native food or are generated by cooking or
other treatments. Additionally, depending on the metabolites that
are generated and on the body compartments where they are
dispatched, the products of NAT2 activity can exert carcinogenic
or toxic effects [7].
Thanks to the well-established genotype-phenotype correlation,
the overall population prevalence of the acetylator phenotype can
be inferred from the population frequency of variants known to
affect NAT2 function. Because of its medical interest, the
geographic distribution of NAT2 variants has been well charac-
terized. This distribution shows a belt of populations with high
frequencies of the slow-acetylator allele(s) stretching from Europe
to central and northern Africa to southern Asia; in constrast,
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are characterized by higher frequencies of the fast acetylator
allele(s) (Fig. 1, data from [6,8] and references therein). Wilson et
al. [9] analysed NAT2 and other genes coding for drug
metabolizing enzymes and found greater heterogeneity among
genetically-defined than ethnically-defined populations. This
finding suggests that a population’s drug-metabolizing repertoire
is likely to vary across local populations within broadly defined
human groups. These findings raise the question of whether the
current geographic distribution of NAT2 variants is the result of
human adaptations to different and changing environments. It is
implicit that such adaptations were induced by long-term exposure
to environmental chemicals and dietary components rather than
medical drugs, which were introduced too recently to result in any
considerable selective effect.
Here, we report on the pattern of genetic variation at NAT2
coding region in 12 human populations that significantly extend
the geographic range (Fig. 1) and resolution of previous NAT2
surveys [8,10–12]. In this study, populations were selected
according to two criteria: i) they represent a wide spectrum of
environmental and dietary regimens that may have shaped NAT2
variation and ii) they represent test samples of large national
communities that may become exposed to drugs metabolized by
NAT2 isoenzymes for the treatment of a number of diseases of
major Public Health importance (e.g. tuberculosis). Moreover, the
ongoing westernization of the life style and diet of these same
communities e.g. [13] is likely to modify substantially their cancer
risk, which is also a function of their NAT2 genotypic pool. Our
results show that spatially and temporally varying selection
reflecting different dietary regimens and lifestyles may explain
inter-population differences in NAT2 variation.
Results
Twelve population samples were included in our study of NAT2
variation; these populations cover a geographic area extending
from Africa North of the equator to South and East Europe and
North East Asia to the Beringian coast. The extremes of the
geographic range include three African populations (Dendi from
Nigeria and the Amhara and Oromo from Ethiopia) and a
Siberian population from the Chukotka peninsula. We selected
small sub-samples (6–14 individuals) from 9 of the 12 above
sampling locations for a full re-sequencing survey (referred to as
‘‘re-sequencing panel’’, see Supplementary Table S1). Also, seven
known polymorphisms were genotyped in additional 150 individ-
uals from the same 12 populations, bringing the overall number of
genotyped subjects to 248 (referred to as ‘‘extended panel’’, see
Supplementary Tables S1 and S2).
Re-sequencing survey
The NAT2 gene spans 9.9 kb (Chr 8 positions 18,293,034–
18,302,961 in NCBI B35 assembly) and consists in a non-coding
exon at the 59 end, separated by a 9 kb intron from a
uninterrupted coding region of 873 bp (including the stop codon).
Because a previous study had reported a putative signal of non-
neutral evolution for the NAT2 coding region only [8], we re-
sequenced this region in a total of 98 subjects from nine
populations (listed in Supplementary Table S2), thus significantly
Figure 1. Map of the old world showing the sampling locations for the populations here examined. Each pie represents the percentage
of the slow (white), intermediate (grey), and fast (black) acetylators in the extended panel, inferred from genotype data as described in Materials and
Methods. Inset: map showing the frequency of slow (white) and fast (black) haplotypes as inferred based on biochemical data [6].
doi:10.1371/journal.pone.0003136.g001
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This allowed the search for possible, yet undetected, variants. A
single new variant was found (34T.C); it results in a non-
synonymous change (12Y.H) whose effects on NAT2 function
are unknown. This variant was found in a Chukchee individual
homozygous for two haplotypes otherwise identified as *5B. This
polymorphism was only considered in the neutrality tests and
when calculating Extended Haplotype Homozygosity (EHH).
The remaining 6 polymorphic sites are the ones most commonly
reported in surveys of NAT2 variation in human populations
(http://www.louisville.edu/medschool/pharmacology/NAT.html).
Two are synonymous changes (C282T and C481T), whereas the
remaining four variants are non-synonymous (T341C, G590A,
A803G and G857A). Although G191A is described to be relatively
common in Western Africa (up to 15%) [8,12,14], none of the
subjects in our sample carried this variant.
The ancestral state at each variable position was inferred by
comparison with the chimpanzee and macaque sequences; both
outgroup sequences showed the same nucleotide at each
polymorphic position in humans. We find that haplotype *4
carries the ancestral allele at all variable sites detected in our
survey as well as at all the polymorphisms reported in the NAT2
literature, thus identifying this fast haplotype as the ancestral
arrangement of human polymorphic alleles.
Extensive theoretical work [15–20] has shown that surveys of
ascertained SNPs may introduce a bias in the distribution of allele
frequencies, linkage disequilibrium and polymorphism levels and,
therefore, affect population genetics inferences. In contrast, full re-
sequencing surveys, in which the sequence of a genomic segment is
determined in each individual in the sample, allow an unbiased
characterization of multiple aspects of genetic variation and are
suitable for standard methods of population genetics analyses. In
this sense, the set of 196 (9862) gene copies entirely sequenced for
the NAT2 coding region provides an appropriate data set for
performing statistical tests based on a variety of summaries of
genetic variation data. For this survey, we focused on the portion
of the gene for which a precise genotype/phenotype correlation
has been established [7]; however, we cannot rule out that non-
coding variants exist, which influence NAT2 gene expression and
function. Polymorphism levels were summarized by the estimators
Theta(pi) and Theta(s), which are based on average number of
pairwise sequence differences and on the number of segregating
sites, respectively. In the three continental pools, the estimator
Theta(pi) exceeded the estimator Theta(s) (Table 1). Under the
standard neutral model, the distributions of the two parameters
have the same mean. While chance variation predicts that, in any
given sample, one of the parameters may exceed the other,
Theta(pi) also exceeded Theta(s) in all individual populations
samples (Supplementary Table S3). Consequently, Tajima’s D
[21], a summary statistic of the frequency spectrum based on the
difference between the Theta estimators, was invariably positive in
the continental and in the individual population samples,
indicating the excess of intermediate frequency alleles as a feature
of NAT2 variation.
Table 1 also reports the statistical significance of the departure of
summary statistics from null distributions obtained under three
commonly considered demographic models (see Materials and
Methods). When compared to the results of neutral simulations
under the exponential growth model: Tajima’s D values were
significantly positive for the African and European samples (p,0.05)
and reached borderline significance in the Asian sample; Fay and
Wu’s H reached borderline significance in the European and Asian
samples. When compared to the results of neutral simulations under
the Bottleneck model A: Tajima’s D values were significantly positive
for the African and European samples (p,0.05) and reached
borderline significance in the Asian sample; Fay and Wu’s H was
s i g n i f i c a n ti nt h eA s i a ns a m p l e( p ,0.01). When compared to the
results of neutral simulations under the Bottleneck model B: Tajima’s
D values were significantly positive for the African and European
samples (p,0.05); Fay and Wu’s H was significant in the European
(p,0.05) and Asian (p,0.01) samples.
The non-synonymous variants (T341C, G590A, A803G and
G857A) make a substantial contribution to the overall diversity, as
their Theta(pi) is also always greater than Theta(s) in all
Continents (Table 1, cols. 6 vs 9). These results did not change
when samples were considered analytically, indicating that the
non-synonymous variable sites reaching intermediate frequencies
are in excess, reproducibly across populations (Supplementary
Table S3).
Additionally, both the haplotype count (not shown) and
haplotype diversity (Table 1) in Asian and European populations
significantly exceeded those obtained from the coalescent
simulations under neutral scenarios, assuming the rho value
estimated from the HapMap data for the NAT2 genic region
(0.24).
The partitioning of sequence diversity according to lineages
marked by slow-causing mutations was very informative. The
average number of nucleotide differences between pairs of
sequences (formally identical to Theta(pi) per gene) in the pool
of fast haplotypes was by far the highest (0.75). Conversely, it
turned out to be much lower for the *5, *6 and *7 series (0.13, 0.06
and 0.24, respectively).
We also investigated the haplotype structure in the NAT2 region
by calculating the EHH [22] on both sides of each slow-causing
Table 1. Summary statistics of NAT2 diversity in the continental samples of the resequencing panel.
Population N
1 Hd
2 Theta(pi)%
Theta(pi)%
(Syn)
Theta(pi)%
(NSyn) Theta(s)%
Theta(s)%
(Syn)
Theta(s)%
(NSyn) TD
3 Fay&Wu H
Africa 32 0.562 0.251 0.439 0.197 0.142 0.250 0.111 2.050**^^
## 20.456
Europe 88 0.768*^^
## 0.267 0.465 0.210 0.136 0.200 0.118 2.213**^^
## +0.899*
##
Asia 76 0.829***^^^
### 0.271 0.455 0.218 0.164 0.206 0.152 1.607*^ +1.396*^^^
###
All 196 0.775 0.273 0.465 0.217 0.137 0.172 0.127 2.110 +1.027
1. Number of gene copies; 2.Haplotype diversity; 3. Tajima’s D.
Neutrality test significance under demographic model (see Materials and Methods):
Exponential growth,
*0.1,P,0.05,
**P,0.05,
***P,0.01.
Bottleneck A, ^0.1,P,0.05, ^^P,0.05, ^^^P,0.01.
Bottleneck B,
#0.1,P,0.05,
##P,0.05,
###P,0.01.
doi:10.1371/journal.pone.0003136.t001
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derived allele at positions 341, 590 and 857 showed higher EHH
than the ancestral allele. This difference turned out not to be
significant when tested against simulations under a standard
neutral model.
In order to verify this finding using data from a larger genomic
region, we repeated the same analysis using the HapMap Phase II
data for more than 200 SNPs spanning approximately 100 kb
centered on the NAT2 coding region [23]. The results showed
higher EHH for haplotypes harbouring the derived (slow-causing)
allele at positions 341, 590 and 857 in all HapMap populations on
both sides of these positions (Supplementary Fig. S2b–d, top lines).
Similar results were obtained also for the G191A in Yorubans
(Supplementary Fig. S2b). Qualitatively, EHH profiles were
remarkably similar between Yoruba and the other populations,
more so for fast haplotypes. Taken at face value, this indicates that
non-African populations did not suffer any major bottleneck.
The majority of the common variants are non-synonymous (5
vs. 2 synonymous) and are known to reduce NAT2 activity to a
similar extent. Though this proportion is not statistically significant
in the McDonald-Kreitman test (9 vs. 3 fixed differences between
human and chimpanzee), we notice that this test does not take into
account the frequency of each variant. Instead, our data indicate
that considering allele and haplotype frequencies is crucially
important.
Thus, we provisionally conclude that multiple slow acetylator
mutations contribute an excess polymorphism to the NAT2 coding
sequence. Even though neutral evolution cannot be unequivocally
excluded, the departure of the observed frequency spectrum from
the simulated neutral scenarios, coupled with the presence of
multiple non-synonymous variants with well documented pheno-
typic effects, suggests that positive natural selection drove these
variants to intermediate frequencies at some point during their
evolutionary history. Our resequencing data do not allow us to
distinguish between different selective scenarios (e.g. directional
selection on multiple standing variants vs. balancing selection).
Genotyping data
The 6 common polymorphic variants identified in the
resequencing panel were also genotyped in an additional set of
150 individuals (for a total of 248 individuals) (Supplementary
Tables S1 and S2). Table 2 displays the structure of haplotypes as
well as their population frequencies.
Five of the 6 genotyped SNPs are polymorphic in all samples,
whereas position 857 was polymorphic in all samples but the
Dendi and the Czech.
Only two haplotypes are present in all population samples and
both are derived, i.e. *5B and *6A. The first one exhibits
frequencies above 18% in all the examined populations. The
ancestral haplotype *4 is the third most common, with frequencies
ranging between 0% and 38%.
Figure 1 and the Supplementary Table S1 list the phenotypes in
each population sample divided into fast, intermediate and slow
acetylators, inferred as described above. The results are in
agreement with previous observations, by showing a belt of
populations characterized by the high prevalence of slow and
intermediate acetylators stretching from Eastern Africa to North-
Western Europe. In contrast, a higher prevalence of fast
acetylators is observed in the single Western African sample
examined here and in the Northern Eurasian samples.
The genealogical relationships among haplotypes inferred by
network analysis (Fig. 2), reveal three main features. First, the
haplotypes are connected in a very condensed and highly
reticulated network (Fig. 2, top). It is worth noting that the two
most divergent haplotypes (*5B with 34T.C vs. *6A) differ by 6
substitutions, i.e. only 2.5 fold the average pairwise distance (2.4).
When large, this measure is taken as an indicator of deep-rooted
gene genealogies, possibly maintained by long-term balancing
selection [24]. Second, the networks obtained for each separate
population are very similar. Third, all networks show relatively
common haplotypes at nodes that are two (for *6A) and three (for
*5B) steps apart from the ancestral *4 haplotype, while haplotypes
at intermediate nodes are present in most populations, but occur at
lower frequencies. These results show that, even though we
surveyed geographically diverse populations, we did not find
populations harbouring common haplotypes that are ancestral to
those most represented in contemporary populations, and argue
for a recent increase in frequency of the terminal haplotypes. It is
worth noting that, based on the network reconstruction, the three
key mutations determining the slow acetylator haplotypes (T341C,
G590A and G857A) tend to be more recent than mutations that
do not modify the acetylator status.
Pairwise LD (Supplementary Table S4) diplays strong D’ but
quite low r
2 values. In fact, no two variants are uniquely associated
in a single haplotype (condition to have r
2=1) and several
combinations show the presence of all 4 haploid arrangements in
262 comparisons (e.g. 590G.A vs. 803A.G). This data are
consistent with a relevant role of recombination (or other inter-
chromosomal mechanisms) in reshuffling alleles at different but
very closely spaced positions.
We then sought to further test the consistency of our data with a
scenario of a small population exiting and expanding out of Africa,
the emergence of new variants during this process and the increase
of their frequencies up to intermediate values by neutral processes.
We reasoned that, under this hypothesis, increasing levels of
resolution (i.e. when considering phenotypes, haplotypes and
haplotypes with their molecular distances) should lead to
increasing values of the corresponding fixation index, due to the
ongoing molecular radiation paralleling populations splits and
dispersals. We then measured the intra- and inter-population
quotas of genetic diversity by considering different properties of
NAT2 haplotypes. When analysed individually, all of the 6 variable
positions revealed low FST values, with only A857G reaching 0.04
(Supplementary Table S5). At the haplotypic level, when only two
groups were considered, i.e. fast and slow haplotypes (Table 3, col.
3), we obtained the lowest values for both intra- and inter-
population variances. The corresponding fixation index, FST, was
1.96%, indicating a fairly modest differentiation among the set of
widely dispersed populations. When all 17 haplotypes were
considered, without taking into account their actual molecular
diversity (number of mutations differentiating them), larger
variance components were obtained, as expected. Nevertheless
the FST index was only slightly increased (Table 3, col. 4). Finally,
when molecular distances were considered in the calculation (i.e.
using WST in the AMOVA framework [25]), variance components
reached the highest values, but the fixation index was again not
increased (Table 3, col. 5). In the three conditions, the comparison
between African and Eurasian populations contributed 2/3 to 1/3
of the overall inter-population diversity (not shown).
Nutritional data
Previous studies [8] proposed a selection in favour of 341(T),
which leads to a slow acetylator phenotype, as a consequence of
the shift in modes of subsistence and lifestyle in human
populations. Based on the results presented here and the similarity
of the phenotype produced by slow-causing haplotypes, this
hypothesis can be extended to all of the three slow variants. To test
this hypothesis more directly, we assigned 47 populations to one of
NAT2 in 12 Populations
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of haplotype frequencies across subsistence modes (Table 4).
The pool of fast haplotypes showed a strong decreasing trend in
the order hunter-gatherers/pastoralists/agriculturalist. Frequency
heterogeneity among the categories was significant by the non-
parametric Kruskal Wallis test. Though haplotype frequencies
violate the assumption of independence (due to their summing to
1), it is important to note that both *5 and *6 show a definite
increase among agriculturalists, with a trend significantly depart-
ing from equality.
The vast geographic distance between populations with the
same subsistence modes (especially H-G, Supplementary Figure
S3) makes it unlikely that these results are due to spatial clustering
and preferential gene flow. The evidence regarding the *7
haplotype, which shows the highest frequency among pastoralists,
must be considered cautionarily, due to the overrepresentation of
the closely spaced Central Asians.
Discussion
Unusual features of NAT2 polymorphism
Our resequencing survey of NAT2 variation in geographically
dispersed human populations showed that several aspects of the
data do not fit the expectations of a neutral model. This finding,
coupled with the presence of multiple amino acid polymorphisms
that are widely distributed and that are known to have similar
phenotypic effects, suggests that these variants were advantageous
and that they increased in frequency in parallel in different human
populations.
Several aspects of sequence variation data at the NAT2 gene are
unusual when compared to neutral expectations for demographic
models that were previously shown to fit genome-wide patterns of
variation. For example, while Sub-Saharan African populations
generally tend to have a genome-wide excess of rare variants
which probably reflects a history of recent growth, the frequency
spectrum at NAT2 shows a marked excess of intermediate
frequency variants (positive Tajima’s D), which departed signifi-
cantly from a neutral model of a population at equilibrium
followed by rapid exponential growth. A similar excess of
intermediate frequency variants was observed in non-African
populations, which tend to have positive Tajima’s D values at the
genome-wide level; yet, the Tajima’s D value at NAT2 is unusual
in the European and Asian samples (though only marginally
significant in the latter) when compared to neutral expectations for
two different bottleneck models. Significantly positive figures of
Tajima’s D underline the excess of high frequency polymorphisms
and the paucity of singletons. As it is not computationally feasible
to test all the space of possible demographic scenarios, this result
may still be compatible with the hypothesis of a purely
demographic affect, i.e. a bottleneck experienced by all of the
populations here scored.
Moreover, our results depict a pattern of variation at NAT2 very
discrepant from the average of 313 and 132 genes scored by Stephens
et al. [26] and Akey et al. [27], respectively. The density of SNPs/kb
is large (8.03 vs. 3.4), with a Theta(s) value of the same magnitude but
a very different Theta(pi) (0.273% vs. 0.034%). Based on Theta(pi),
Table 3. Measures of intra- and inter-population diversity by using different inter-haplotypic distances.
Source of variation d.f. Fast vs. Slow haplotypes 17 haplotypes 17 haplotypes and molecular distance
Among populations 11 0.0039 0.0085 0.0196
Within populations 484 0.1941 0.3734 1.1834
Fixation index Fst=0.0196 Fst=0.0223 Wst=0.0163
Significance P=0.049 P=0.001 P=0.029
Variance components are reported in the body of table.
doi:10.1371/journal.pone.0003136.t003
Table 4. Test of equality of frequency of 5 NAT2 haplotype
series among three major modes of subsistence.
Series Subsistence N Avg. Freq. (%) p(Kruskal Wallis test)
All Fast Hunter-gath. 12 52.1 ,.001
Pastoralist 13 35.6
Agriculturalist 22 27.3
*14 Hunter-gath. 12 4.2 .006
Pastoralist 13 0.0
Agriculturalist 22 1.4
*5 Hunter-gath. 12 23.0 .017
Pastoralist 13 27.3
Agriculturalist 22 37.2
*6 Hunter-gath. 12 10.6 ,.001
Pastoralist 13 23.3
Agriculturalist 22 30.0
*7 Hunter-gath. 12 10.2 .002
Pastoralist 13 13.7
Agriculturalist 22 4.0
doi:10.1371/journal.pone.0003136.t004
Figure 2. Median-joining networks of NAT2 haplotypes in the 12 populations of the extended panel. The relationships between the 17
haplotypes found in the pool of the 12 populations are displayed by the network on top, with nodes of fixed size. Vectors representing each
mutation are oriented as shown on top right (e.g. the vector 341 connects haplotypes which differ only at the position 341). Nodes representing fast
and slow haplotypes are color-coded in black and grey, respectively. Networks specific for each population are displayed using the same skeleton and
omitting only unnecessary links. Node size is proportional to the number of observations. Note that three main features of the overall network are
necessary to explain the haplotypic composition of all but two populations (the left-hand ‘‘cube’’ leading to *5B and the right-hand ‘‘planes’’ leading
to *7B and *6A), and that in most cases the median vectors of these structures are actually found. In all graphs the ancestral haplotype *4 is identified
by a lozenge.
doi:10.1371/journal.pone.0003136.g002
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other drug metabolizing genes [28]. Generalized and strongly
enhanced mutation rates at NAT2 can be excluded as Theta(s),
which is an estimator of 4Nem (where Ne is the population effective
size and m the mutation rate), falls into the range reported by
Stephens et al. [26] for all genic regions. However, our results cannot
rule out site-specific mutation proneness.
Also, there is a preferential polymorphism at non-synonymous
sites. Six variants have intermediate frequencies above 5%
worldwide, four of which are non-synonymous (non-synony-
mous/synonymous ratio=2), contrasting with the findings by
Wong et al. [29] for SNPs with Minor Allele Frequency (MAF)
above 6.1% (non-synonymous/synonymous ratio ,0.5). The
percentage of synonymous substitutions is only two thirds of that
reported by Stephens et al. [26](2/7 not conditioned on frequency
vs. 459/1033). We indeed measured the dN/dS ratio in a tripartite
tree including human, chimp and macaque sequences (rodents as
outgroup) and found this ratio largely increased in NAT2 (0.71) as
compared to NAT1 (0.28). As a minimal interpretation, this is in
agreement with a long-lasting relaxation of selection on NAT2.
However, the observation that 3 out of the 4 human polymorphic
non-synonymous substitutions are also responsible for NAT2 slow
acetylation activity (slow-causing variants) support the hypothesis
that this could be an adaptive trait subjected to some form of
selection in the recent past or even today. Network analysis turned
out to be a powerful tool to indicate that haplotypes *5B, *6A and
*7B stem out from low-frequency haplotypes radiating from the
ancestral *4, which is still today an intermediate frequency
haplotype. This is a pattern representing an obvious departure
from the shape expected under neutrality and is responsible for the
excess of positive Tajima’s D values and the maintenance of longer
EHH on slow haplotypes. These features can be hardly perceived
if examining only numerical data such as linkage disequilibrium
(LD) estimators (Supplementary Table S4).
Finally, low fixation indexes over a transept crossing the Old
World, place NAT2 at one edge of the genome-wide distribution [30].
Our results can be summarized and interpreted as follows: 1) the
NAT2coding region is poorly differentiated in the population samples
examined (absolute values of the fixation indexes); 2) the major
determinant of inter-population diversity are the phenotypic
proportions (the first fixation index value in Table 3 is not lower
than the others); 3) population dispersals were not accompanied by a
concomitant accumulation of molecular diversity (similarity between
the 2
nd and 3
rd fixation index); 4) the data fit the distribution obtained
by Currat et al. [31] for neutral alleles already attaining polymorphic
frequencies at the time of exit out of Africa [32].
From a phylogeographic perspective, the consistency of the
networks across different populations means that all the major
haplotypes had originated prior to the differentiation of the study
populations. However, the out-of-Africa bottleneck predicts lower
diversity levels in non-African compared to African populations,
and this is not observed at the NAT2 locus. There is no marked
tendency of any of the derived NAT2 haplotypes to be continent-
specific. In addition, our data display an enhanced frequency of the
ancestral *4 haplotype out of Africa, a feature exhibited by only a
subset of genes reported in the literature [for reviews see 33,34].
This indicates that heterogeneity of NAT2 haplotype frequencies
cannot be appropriately predicted by geography alone. Thus, a
simple model of variation pre-existent within Africa, spreading out
of Africa and evolving by neutral drift is unsatisfactory. Rather, the
finding of an independent categorizing variable (subsistence style),
which is able to unveil frequency heterogeneity also on a restricted
spatial scale [11,12], and contrasting EHH patterns [8], suggest
that NAT2 variation was shaped by environmental features.
Deciphering a selective scenario
Several features of the data generated by us and by others
[8,10–12] suggest that selection acted on multiple slow-causing
variants. There are two main models of selection that may
generate patterns of variation similar to those observed at the
NAT2 gene: balancing selection and directional selection on
multiple standing variants.
A markedly positive Tajima’s D value, as observed at the NAT2
gene, is expected under balancing selection [35,36], which can act
in the form of heterozygote advantage, frequency-dependent
selection or changes in the selective regime over time and/or
space. This pattern in the frequency spectrum is a function of the
equilibrium frequency of the balanced polymorphism and may be
observed in the case of a bi-allelic or a multi-allelic polymorphism
[37,38]. An additional feature of balanced polymorphisms is an
excess of diversity, but this is expected only in the case of long-
standing selection, i.e. longer than 4Ne generations. Therefore, the
marked positive Tajima’s D value at NAT2 may be explained by a
model of relatively recent balancing selection on NAT2 non-
synonymous variation. The data cannot distinguish between a
recent onset and a recent increase in the strength of balancing
selection. In either case, the presence of multiple of non-
synonymous variants with well documented phenotypic effects
suggests selection maintained multiple alleles.
Alternatively, the findings at NAT2 may be explained by a model
of directional selection acting on multiple standing variants, i.e.
variants that segregated in the population prior to the onset of
selection; these variants may have been completely neutral or
slightly deleterious before they became advantageous. Due to the
rapid environmental changes occurred during human evolution, a
number of investigators have postulated that selection on standing
variation (rather than selection on a new beneficial allele) played a
major role in human adaptations, thus affording a more rapid
adaptive response to the environmental change. A variety of
scenarios of directional selection on standing variation have been
modelled to determine the expected signature of selection (for
reviews see [35,39,40]). These models may prove particularly useful
to understand the pattern of variation at NAT2. Specifically,
Pennings and Hermisson [41] showed that Tajima’s D may take
markedly positive values, as we observe in the NAT2 coding region,
when directional selection acts on multiple existing variants. If
multiple variants segregating in a population are concurrently
driven to intermediate frequency by positive selection, the variation
tightly linked to these variants will also tend to occur at intermediate
frequencies, thus generating a skew in the frequency spectrum. In
addition, high EHH around the putative advantageous variants
may also be observed, though the power of this test for such a
selection scenario has not been investigated.
The worldwide pattern of variation at NAT2 individual SNPs
and haplotypes is barely compatible with molecular radiation after
population dispersals out of Africa, because it would require later
abundant gene flow back into Africa. Conversely, these findings
can be easily explained by the presence of NAT2 polymorphism
prior to the exit out of Africa. Within each of the allelic series the
repertoire of NAT2 haplotypes fit the expectations worked out
theoretically by Przeworski et al. [42] for a scenario of selection
beginning to act on accumulated neutral variation. In this case,
many recombination events occur when the allele(s) that will
become selected sojourn(s) in the population as neutral variant(s).
However, in one aspect the models proposed by Pennings and
Hermisson [41] and Przeworski et al. [42] do not fit the NAT2
case. In fact they assumed that the beneficial alleles are fixed in the
population, thus focusing on a linked neutral locus. Instead, based
on biochemical data on the effect of mutations on NAT2
NAT2 in 12 Populations
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background, all slow-causing mutations had an equivalent effect
on phenotype and fitness. If two or more of these mutations were
picked up by selection and simultaneously started to increase in
frequency, at some point they started to interfere with each other,
thus preventing the fixation of any allele and the sweep itself.
Under such a complex scenario current methods to detect the
signature(s) of selection have little power. This may explain the
failure of four genome-wide scans in detecting selection at NAT2.
In the study by Bustamante et al. [43] NAT2 did not emerge and
no genes were reported under positive selection in the GO
categories to which it belongs (MF=acyltransferase; BP=other
metabolism). No indicator of selection was significant in the study
by Voight et al. [44], with peaks of marginal significance only at
PSD3, a gene located 200 kb 39 to NAT2. In the analysis by Wang
et al. [45], which is based on data largely overlapping with the
previous work, NAT2 falls in a chromosomal region devoid of
signals. Finally, no evidence for selection in the NAT2 region was
detected in HapMap phase II data [23].
In conclusion, our data favour the hypothesis that a selective
pressure drove at least three slow-causing variants to the
frequencies observed today, but do not allow us to discriminate
between balancing selection and directional selection on multiple
standing variants. While some aspects are in line with balancing
selection, parallel directional positive selection favouring all slow
causing mutations cannot be ruled out, as was first proposed by
Patin et al. [8] when considering the *5 series alone.
A testable model for a putative selective factor
Our model of selection acting on the *5, *6 and *7 series is
supported by the presence of all these haplotypes in widely
dispersed populations as contrasted with the strong heterogeneity
of their frequencies according to the subsistence style. As
populations were sampled in geographically distant locations (see
Supplementary Figure S3), co-inheritance of both subsistence style
and composition of the gene pool due to shared ancestry is
unlikely. Thus, some degree of selection depending on the main
food source, or some yet unidentified covariate of it, is the most
parsimonious explanation [6 p. 8,44].
It is to be noted that the two competing selection models
mentioned above both imply that the fast-acetylator phenotype
began to suffer a selective disadvantage. This is straightforward in
the case of positive selection but has to be assumed also in the case
of balancing selection, as the frequency of the pooled slow-causing
variants is now well above 50% worldwide.
Several studies have pointed out a possible role of NAT
enzymes in the catabolism of folates, possibly via the acetylation of
p-ABGlu [for reviews see 46,47]. However, the specific question of
the relative roles of enzymes encoded by NAT1 and NAT2 in
maintaining the overall folate balance in humans has not been
directly addressed. Kawamura et al. [3] showed that the affinity of
both human NAT1 and NAT2 for p-ABGlu is reduced to a similar
extent as compared to each enzyme’s best substrate (PABA and
hydralazine, respectively). The fact that the liver is the main organ
where folate is stored and is also the main site of NAT2 expression,
suggests a non negligible role of NAT2 as compared to NAT1.
Different observations indicate possible overlapping effects of
folate levels and NATs activity. The overexpression of the
orthologue of human NAT1 in mouse embryos causes develop-
mental abnormalities which are reminiscent of spina bifida-like
phenotype [46,48]. Accordingly, reduced NAT1 activity in
humans has been related to a reduced risk of spina bifida [49], a
condition well known to be associated with low levels of folates in
pregnant mothers.
It is likely that populations shifting from hunting-gathering (H-
G) to agriculture became exposed to drastic fluctuations in the
supply of folates and to long periods of deprivation. Folates are an
essential constituent of the diet, abundant in green leaf vegetables
and animal liver, i.e. regular components in the diet of H-G in the
terrestrial and marine environment, and in many pastoralist
cultures (e.g. the Yakuts). On the contrary, cereals and grains are
poor sources of folates, which are further degraded upon storage
and cooking [50]. The clinical effects of such a shift, on a short
time frame, have been verified in a follow-up study of a !Kung San
population [51].
Based on the above elements and the relevance of folates in the
etiology of neural tube defects (e.g. OMIM #601634) and in a
number of functions related to successful reproduction for reviews
see [52,53], we propose the following model for the increase in
frequency of multiple NAT2 slow haplotypes under changing
dietary regimens:
i) A fast acetylating phenotype is neutral (or even advantageous)
only in the presence of a folate-rich diet, a situation fulfilled
among H-G;
ii) Conversely, when the supply of folates becomes limiting (as
might be in the case of a nutritional shift to agriculture), the
fitness of fast acetylators drops, due to increased folate loss;
iii) In the same conditions, the slow (or possibly the intermediate)
acetylator phenotype, by favouring folate retention, reduce the
load caused by fetal loss, birth defects and sub-optimal
maternal fertility. Any slow-causing haplotype thus acquires a
fitness higher than the fast ones.
The above model relies on the assumption that NAT2 brings an
extra contribution to the overall rate of folate catabolism, which is
otherwise mainly determined by NAT1. This assumption can be
experimentally tested biochemically, in vitro, and by correlating
NATs phenotypes and folate levels in vivo. A necessary corollary is
that, while NAT1 activity is strictly physiologically constrained,
variation at NAT2 determines whether the overall rate of folate
catabolism becomes critical in the presence of reduced folate
supply.
The model easily allows for a small selective advantage of all
multiple slow-causing NAT2 allelic variants, which may explain the
growing phase in their frequency trajectory, independently of the
underlying biochemical mechanism. The observation that this
mechanism often is reduced protein stability [54] leads to the
prediction that activity is equally reduced for all substrates,
including folate catabolites.
Also, the putative reduction of fitness of fast NAT2 variants in
the presence of low folate supply predicted by our model, applies
to a condition that impacts directly on the reproductive success.
On a microgeographic scale, the frequency of NAT2 slow
variants is not easily predictable based on the subsistence style.
This is because even populations whose main caloric source are
cereals and grains may have historically complemented their diets
with valuable sources of folates. This might be the case for Eastern
Asian populations, in which the highest frequencies of *4 are
observed, despite a rice-based diet (rice being among the poorest
sources of folate). For example, in this case, consumption of brown
rather than white rice and/or large amounts of fish (as in the
Japanese population) may have re-established adequate amounts
of folates. Additional aspects to be considered are food diversity,
regularity in feeding (hypocaloric stresses being more severe in H-
G) and cooking habits (temperature). Finally, further dietary
heterogeneity within the three broad categories might be relevant.
For example Perry et al. [55] showed that selection pressure on the
NAT2 in 12 Populations
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which is known to vary greatly among H-G’s of the arid, rainforest
and circum-arctic environments.
In our model, ancestral haplotypes (mainly *4 but also *11, *12
and *13) were compatible with pre-agricultural environmental
conditions but begun to determine sub-optimal fitnesses as humans
changed lifestyles with or without dispersing into new environ-
mental niches. From this point of view they can be considered bona
fide ancestral susceptibility alleles [56].
In conclusion, we propose that the present NAT2 diversity in
human populations is the result of three distinct processes: i)
presence of variation for slow-causing sites in widely dispersed
populations (possibly as neutral variation) before major shifts to
pastoralism and/or agriculture as the main modes of food
production; ii) independent emergence of selective advantage for
multiple slow-causing mutations in populations shifting from H-G
to pastoralism/agriculture; iii) further introgression of slow-causing
variants into populations anchored to H-G by later gene flow.
Materials and Methods
The subjects
Samples from Nigeria (Dendi, coded WAF in Fig. 1), Ethiopia
(Amhara [AMH] and Oromo [ORO]), Egypt [EGY], Italy [ITA],
Czech Republic [CZK] and Greece [GRE] were previously
described [57–60], whereas the remaining population samples (i.e.
Mordovians [MOE], Perm Russians [PER], Khanti and Mansi
[K&M], Yakut [YKL], Chukchee [CHK]) are described here for
the first time. All samples were collected personally by one or more
of the authors during field campaigns, as consecutive series of
unrelated subjects. Field work included the assessment of
subsistence style for each population sample. The subjects to be
collected were randomly chosen, without selecting for their clinical
status or the presence/absence of digestive disturbances.
DNA was extracted from either buccal swab or dried blood
adsorbed on paper, with commercially available kits (NucleoSpin,
Macherey-Nagel GmbH, Duren, Germany) according to the
manufacturer’s instructions. Khanty and Mansi subjects were
lumped in a single sample. All samples were collected upon written
or oral informed consent. This study was approved by the
University of Calabria intramural Ethical Committee.
All populations studied here and 35 additional ones from
published NAT2 surveys were classified into the three main
subsistence style categories: hunter-gatherers (H-G), pastoralists
and agriculturalists as defined in Bromley [61] and references
therein or in the original reference (see Supplementary Tables S1
and S6).
Nomenclature
In contrast with the pharmacogenetic literature, in which the
term allele is used to indicate protein variants and corresponding
DNA sequences regardless of the number of mutations, we use the
term allele to indicate the variant at each nucleotide position and
the term haplotype to indicate the overall sequence. Also, note that
in the pharmacogenetic literature, protein variants are grouped
into series, each of which is characterized by the presence of a
specific DNA substitution (for details see http://www.louisville.
edu/medschool/pharmacology/NAT.html). We refer to them by
omitting the prefix ‘‘NAT2’’ (e.g. *4 instead of NAT2*4). Moreover,
the pool of series *4, *11, *12 and *13 is referred to as fast
acetylator haplotypes, whereas the pool of the remaining series is
referred to as slow acetylator haplotypes [7]. Nucleotide positions
are numbered according to the coding sequence (Acc. no.
D90042.1).
The orthologous NAT2 sequences for the common chimpanzee
(Pan troglodytes) and the rhesus macaque (Macaca mulatta) were
obtained by BLAST using the human coding sequence. These
sequences were unambiguously aligned and compared to the
human sequence to determine the ancestral state at each
polymorphic position.
Re-sequencing
DNA from all subjects was subjected to a two-step nested PCR
protocol to isolate NAT2 from the paralogous NAT genes [8].
Resequencing was performed on the PCR product with
standard protocols for ABI310 automatic Sequencer. Electrophe-
rograms were aligned with the reference sequence and visually
inspected. Ambiguous polymorphisms were confirmed/dismissed
by sequencing the opposite strand. The single instance of a novel
mutation passing this step, i.e. 34T.C, was further confirmed by
restriction analysis as it determines the gain of a HaeIII site.
SNP genotyping
The following genotyping protocol was adopted: C282T
(rs1041983), C481T (rs1799929), G590A (rs1799930), A803G
(rs1208) and G857A (rs1799931) were typed according to a
restriction fragment length analysis protocol modified from Deitz
et al. [62], on the nested PCR product. T341C (rs1801280) was
assayed by an allele-specific PCR protocol modified from Bakayev
et al. [63]. Since in compound heterozygotes the products
obtained with this allele-specific PCR contain markers in a
haploid form, the same assay was also used to determine the phase
of specific variants with respect to position 341 by either digestion
with restriction enzyme (Supplementary Fig. S1) or re-sequencing.
African samples were also genotyped at the G191A variant
(rs1801279), which was previously found only in African
populations [8,14]. This was done by digesting the nested PCR
product with HapII in all carriers of haplotypes with the ancestral
state at all the positions 341, 590 and 857.
Data analysis
Haplotypes were inferred in each population sample using the
program PHASE (ver. 2) [64]. Genotypes whose phase was
reconstructed with posterior probability ,0.70, or corresponding
to haplotypes never described before (http://www.louisville.edu/
medschool/pharmacology/NAT.html), were subjected to experi-
mental validation of the inferred phase, as described above.
The acetylator phenotype for each individual was inferred by
assuming that the homozygous or compound heterozygous
genotype for two haplotypes of the series *4, *11, *12 or *13
results in the fast acetylator status, the occurrence of one of these
haplotypes in combination with a haplotype of the series *5, *6 or
*7 results in the intermediate acetylator status and the occurrence
of two haplotypes of the series *5, *6 or *7 results in the slow
acetylator phenotype [7,14,65].
EHH was calculated as described [22] using the program Sweep
(http://www.broad.mit.edu/mpg/sweep/index.htm). Core haplo-
types were defined for each SNP known to affect NAT2 activity.
The EHH for each core haplotype carrying the derived (slow-
acetylator) allele was compared to: 1) the EHH for all the
remaining haplotypes; and 2) the EHH for the subset of haplotypes
carrying the ancestral (fast acetylator) allele at all of the SNPs
known to affect NAT2 activity. This analysis was performed on all
the data collected in our population samples as well as in the
HapMap Phase II data [23] for a region of 100 kb surrounding
NAT2 (chromosome 8 positions 18,250,000 to 18,350,000).
Median joining networks were constructed using the program
NETWORK, ver. 4.1.1.2 [66]. The DNAsp package [67] was
NAT2 in 12 Populations
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(Theta(pi), Theta(s), haplotype diversity, Tajima’s D and Fay &
Wu’s H) [21,68], and to perform the McDonald and Kreitman
[69] test.
Measures of intra- and inter-population diversity were obtained
using the Arlequin 3.01 package [70]. When haplotypes were
considered, the fixation indexes were computed with and without
information about inter-haplotype molecular distances.
The equality of frequencies across subsistence styles was tested
by the non-parametric Kruskal Wallis test as implemented in
SPSS.
For all tests of neutrality, coalescent neutral simulations were
run under different demographic models to assess the significance
of the resequencing data. For all continental samples (i.e. Africa,
Europe, Asia), 10,000 replicates were generated using the program
MS [71], under three demographic models: i) an exponential
growth model with exponential growth rate of 0.183, typical for
the African population; ii) bottleneck model A, with a bottleneck of
severity 0.1 starting 1200 generations before present and lasting
400 generations, typical for the European population; iii)
bottleneck model B, with a bottleneck of severity 0.3 starting
1200 generations before present and lasting 400 generations,
typical for the Asian population [72]. The numbers of segregating
sites were fixed at the values obtained from the re-sequencing data,
the population recombination rate parameter rho (=4Nr, where
N is the population effective size and r the recombination rate
between adjacent sites per generation) was assumed to be 0.24,
based on published estimates [73] using the HapMap data for the
genomic segment spanning the NAT2 gene.
Supporting Information
Figure S1 Typing and phasing of mutations by means of allele-
specific PCR. Panel A: PCR specific for alleles at pos. 341. Odd
lanes: products specific for allele T. Even lanes: products specific
for allele C. Lanes 1–2 and 7–8: results in subjects T/C; lanes 3–4:
results in a subject T/T; lanes 5–6: results in a subject C/C. Panel
B: Phasing of A803G with respect to T341C in a double
heterozygote. PCR products as in panel A (lanes 1–2) were
digested with DdeI. Lane 1: Molecular weight marker; lane 2: The
product specific for 341(T) [panel A, lane 1] shows the lack of a
DdeI site [803(A)], denoted by the 450 bp fragment; lane 3: The
product specific for 341(C) [panel A, lane 2] shows the presence of
a DdeI site [803(G)], denoted by the 423 bp fragment.
Found at: doi:10.1371/journal.pone.0003136.s001 (2.09 MB TIF)
Figure S2 Extended Haplotype Homozygosity (EHH, y axes) vs.
physical distance (x axes) for haplotypes carrying mutations which
determine the slow acetylator status. The mutations considered are
shown on top and are given reference position 0 (vertical bar). For
each entry, two plots are shown: in the first one (top) EHH on
haplotypes carrying the derived (slow-causing) allele is shown in
grey and is compared to EHH on all the remaining haplotypes (in
black); in the second one (bottom) the same EHH as above (grey) is
compared to the EHH on the subset of fast haplotypes (i.e.
carrying the ancestral state at slow-causing positions other than the
one assayed) (in black). Note that grey profiles are identical within
plot pairs. a) pool of NAT2 haplotypes analysed in the present
study (physical distance covering the NAT2 coding region, in bp);
b) Yorubans from the HapMap database ; c) Caucasians from the
HapMap database; d) Japanese and Chinese from the HapMap
database. In b,c,d physical distance covers chromosome 8
positions 18,250,000–18,350,000, in kb from NAT2 59 end.
Found at: doi:10.1371/journal.pone.0003136.s002 (0.25 MB TIF)
Figure S3 Map showing the location of 47 populations for which
the frequencies of NAT2 haplotype series have been analysed as a
function of subsistence style. Populations are coded as in
Supplementary Table S6.
Found at: doi:10.1371/journal.pone.0003136.s003 (0.13 MB TIF)
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